SCHEMBL7547229

SCHEMBL7547229

COc1cccc(-c2cncc(-c3cn(CC(C)CN(C)C)c4c(OC)cccc34)c2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.51
FLT1 P17948 1/20 0.51
FLT4 P35916 1/20 0.51
CNR2 P34972 2/20 0.39
BRD4 O60885 1/20 0.37
AVPR1B P47901 1/20 0.36
CYP11B1 P15538 2/20 0.35
CYP11B2 P19099 2/20 0.35
PDGFRB P09619 1/20 0.35
PDGFRA P16234 1/20 0.35
MAPK1 P28482 4/20 0.35
LMNA P02545 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 2/20 0.35
CHRM2 P08172 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
CHRM1 P11229 1/20 0.35
DRD1 P21728 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7545417 0.92 KDR (0.52) KDRFLT1FLT4CNR2BRD4
SCHEMBL7990694 0.92 KDR (0.56) KDRFLT1FLT4CNR2BRD4
SCHEMBL7546769 0.90 KDR (0.51) KDRFLT1FLT4CNR2FYN
SCHEMBL7504851 0.87 KDR (0.51) KDRFLT1FLT4CNR2BRD4
SCHEMBL7547790 0.87 KDR (0.68) KDRFLT1FLT4BRD4AVPR1B
SCHEMBL7546645 0.87 FLT1 (0.40) KDRFLT1FLT4CNR2BRD4
SCHEMBL7990474 0.86 KDR (0.71) KDRFLT1FLT4CNR2PDGFRB
SCHEMBL7507277 0.85 KDR (0.58) KDRFLT1FLT4BRD4AVPR1B
SCHEMBL7555811 0.83 KDR (0.50) KDRCNR2BRD4CYP11B1CYP11B2
SCHEMBL7505482 0.82 KDR (0.54) KDRFLT1FLT4BRD4AVPR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed